As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.
Discover >Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.
Discover >Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.
Discover >Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.
Discover >#Health / Well-being
Personalized and sustainable Cosmetic House inspired by various and unique beauties.
The innovative Maison M lipstick delivers any shade customized by its user.
Background
Inspired by my aunt, Odile, to develop innovative, immersive and customized experience as well as optimize our daily routine.
DESCRIPTIF DES PRODUITS / SERVICES / TECHNOLOGIE
The Maison M lipstick offers any shade customized by its user.
Its unique and innovative lipstick case includes 3 custom shades to fit with elegance any situation.
The French and natural products take care of us, our skin and the environment.
– Patented
– 15 rewards
2 patents
STRENGTHS: a complementary and expert team, a patented innovation, a low environmental impact
INNOVATION ASSETS: High technology and IA reinforce customized experience
Dans la même thématique
AGS Therapeutics is a biotech company pioneering the use of microalgae extracellular vesicles (MEVs) as a universal delivery system for innovative therapeutics, vaccines and gene therapies.
Discover
A protein-based nanofilm technology offers the first non-toxic, semi-permanent hair treatment that allows users to safely change their hair style without damage.
Discover
BioHive provides advanced analysis for dermatological products using innovative skin organoids derived from human stem cells, for toxicity and efficacy evaluations.
Discover
Alt Biotech offers an innovative bioproduction platform for non-therapeutic recombinant proteins: productive, scalable, with low environmental impact
Discover
Vitropep developed a unique technology allowing to inject certain peptides without cold chain and with self-administration.
Discover
Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.
Discover
Platform for the bioproduction of RNA through fermentation in eukaryotic cells, a paradigm shift from in vitro synthesis
Discover
Kyron.Bio is a biotech company using synthetic biology to produce new therapies with high yield, activity, and stability standards.
Discover
CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.
Discover
Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.
Discover
Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.
Discover
Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease
Discover
The aim of StemSelect is to pave the way for a general access to cell therapy. The company develops a rapid isolation method of stem cells derived from one’s own fat tissue.
Discover
Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).
Discover
Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.
Discover
IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.
Discover
Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.
Discover
Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota.
Discover
Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.
Discover
